Li Guangwei, Zhang Ping, Wang Jinping, Gregg Edward W, Yang Wenying, Gong Qiuhong, Li Hui, Li Hongliang, Jiang Yayun, An Yali, Shuai Ying, Zhang Bo, Zhang Jingling, Thompson Theodore J, Gerzoff Robert B, Roglic Gojka, Hu Yinghua, Bennett Peter H
Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China.
Lancet. 2008 May 24;371(9626):1783-9. doi: 10.1016/S0140-6736(08)60766-7.
Intensive lifestyle interventions can reduce the incidence of type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabetes, diabetes-related macrovascular and microvascular complications, and mortality.
In 1986, 577 adults with impaired glucose tolerance from 33 clinics in China were randomly assigned to either the control group or to one of three lifestyle intervention groups (diet, exercise, or diet plus exercise). Active intervention took place over 6 years until 1992. In 2006, study participants were followed-up to assess the long-term effect of the interventions. The primary outcomes were diabetes incidence, CVD incidence and mortality, and all-cause mortality.
Compared with control participants, those in the combined lifestyle intervention groups had a 51% lower incidence of diabetes (hazard rate ratio [HRR] 0.49; 95% CI 0.33-0.73) during the active intervention period and a 43% lower incidence (0.57; 0.41-0.81) over the 20 year period, controlled for age and clustering by clinic. The average annual incidence of diabetes was 7% for intervention participants versus 11% in control participants, with 20-year cumulative incidence of 80% in the intervention groups and 93% in the control group. Participants in the intervention group spent an average of 3.6 fewer years with diabetes than those in the control group. There was no significant difference between the intervention and control groups in the rate of first CVD events (HRR 0.98; 95% CI 0.71-1.37), CVD mortality (0.83; 0.48-1.40), and all-cause mortality (0.96; 0.65-1.41), but our study had limited statistical power to detect differences for these outcomes.
Group-based lifestyle interventions over 6 years can prevent or delay diabetes for up to 14 years after the active intervention. However, whether lifestyle intervention also leads to reduced CVD and mortality remains unclear.
强化生活方式干预可降低糖耐量受损人群患2型糖尿病的风险,但这些益处超出积极干预期的时长,以及此类干预是否能降低心血管疾病(CVD)风险和死亡率,尚不清楚。我们旨在评估强化生活方式干预对糖尿病风险、糖尿病相关大血管和微血管并发症以及死亡率是否具有长期影响。
1986年,来自中国33家诊所的577名糖耐量受损成年人被随机分配至对照组或三个生活方式干预组之一(饮食、运动或饮食加运动)。积极干预持续6年,直至1992年。2006年,对研究参与者进行随访,以评估干预的长期效果。主要结局为糖尿病发病率、CVD发病率和死亡率以及全因死亡率。
与对照组参与者相比,在积极干预期间,综合生活方式干预组的糖尿病发病率降低了51%(风险率比[HRR]0.49;95%置信区间0.33 - 0.73),在20年期间降低了43%(0.57;0.41 - 0.81),对年龄和诊所聚类进行了控制。干预参与者的糖尿病年均发病率为7%,而对照组为11%,干预组的20年累积发病率为80%,对照组为93%。干预组参与者患糖尿病的时间平均比对照组少3.6年。干预组和对照组在首次CVD事件发生率(HRR 0.98;95%置信区间0.71 - 1.37)、CVD死亡率(0.83;0.48 - 1.40)和全因死亡率(0.96;0.65 - 1.41)方面无显著差异,但我们的研究检测这些结局差异的统计效力有限。
基于组的6年生活方式干预可在积极干预后长达14年预防或延缓糖尿病。然而,生活方式干预是否也能降低CVD和死亡率仍不清楚。